SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-191889
Filing Date
2019-07-10
Accepted
2019-07-10 16:22:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d776323d424b5.htm 424B5 451721
2 GRAPHIC g776323g92c43.jpg GRAPHIC 9757
  Complete submission text file 0001193125-19-191889.txt   466417
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-218607 | Film No.: 19949556
SIC: 2834 Pharmaceutical Preparations